Home › Funds › ARMISTICE CAPITAL, LLC › MGNX

ARMISTICE CAPITAL, LLC position in MGNX

MACROGENICS INC · Health Care

ARMISTICE CAPITAL, LLC reported holding 5,006,752 shares of MGNX (MACROGENICS INC) in its Q2 2026 13F filing — a position valued at US$23.1M, representing 0.30% of its reported portfolio and ranking #48 among its reported holdings. ARMISTICE CAPITAL, LLC has disclosed MGNX holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

Latest position (Q2 2026)5.01M sh
Reported value held$23.13M
Portfolio Weight0.30%
First reportedQ3 2023
Last changeReduce
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How ARMISTICE CAPITAL, LLC's MGNX position evolved

ARMISTICE CAPITAL, LLC first disclosed a stake in MGNX in Q3 2023 at 4,712,000 shares (US$22.0M). The position peaked in Q4 2023 at 4,572,000 shares, worth US$44.0M. Across 12 filings, ARMISTICE CAPITAL, LLC increased the stake 3 time(s), trimmed it 5 time(s) and left it unchanged 3 time(s). The most recent filing (Q2 2026) shows 5,006,752 shares valued at US$23.1M — a reduction of -1,005,248 shares quarter over quarter.. Notable position changes include a 48% trim in Q1 2024 (shares fell 71% over the following quarter), a 150% increase in Q2 2024 (shares fell 23% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 4.71M $21.96M New
Q4 2023 4.57M $43.98M Reduce
Q1 2024 2.40M $35.33M Reduce
Q2 2024 6.00M $25.50M Add
Q3 2024 6.26M $20.59M Add
Q4 2024 6.28M $20.40M Hold
Q1 2025 6.30M $8.00M Hold
Q2 2025 5.96M $7.21M Reduce
Q3 2025 5.96M $10.01M Hold
Q4 2025 6.32M $10.18M Add
Q1 2026 6.01M $17.37M Reduce
Q2 2026 5.01M $23.13M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About MGNX and 13F data

MGNX (MACROGENICS INC) is a Health Care company. 22 other funds we track also report a position in MGNX. Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding MGNX

No other tracked fund reports a position in MGNX.

All MGNX fund holders →

FAQ

How long has ARMISTICE CAPITAL, LLC held MGNX?

ARMISTICE CAPITAL, LLC has disclosed MGNX holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

What is ARMISTICE CAPITAL, LLC's current position in MGNX?

As of Q2 2026, ARMISTICE CAPITAL, LLC holds 5.01M shares of MGNX (MACROGENICS INC), valued at $23.13M, representing 0.30% of its reported portfolio and ranking #48.

Has ARMISTICE CAPITAL, LLC been buying or selling MGNX?

In the latest 13F filing (Q2 2026), ARMISTICE CAPITAL, LLC reduced its position in MGNX. The position peaked in Q4 2023 at 4.57M shares.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.